Stories of Physics2Market Fund
The Physics2Market fund offered researchers the opportunity to take physics research from lab to society. For example, by building a prototype or proof-of-concept study, collaborations with companies emerged. Raoul Frese – assistant professor at the Faculty of Science, Biophysics Photosynthesis/Energy at Vrije Universiteit Amsterdam – received the last Physics2Market subsidy to further develop material to substitute mineral wool in greenhouses. Another example is Mazi Jalaal, assistant professor at the Institute of Physics at the University of Amsterdam. He received a Physics2Market grant to work out his idea on a new technique to measure the mechanical properties of soft materials, based on image processing and artificial intelligence. The fund was eligible for Researchers (permanent staff, incl. tenure track) of HvA, UvA, VU, Amsterdam UMC, Amolf and Nikhef.
Explore other Stories:
Five years of Amsterdam Venture Studios
The academic incubator facility Amsterdam Venture Studios has found its place in the heart of five campus locations in Amsterdam (Startup Village on Amsterdam Science Park, LawHub on Roeterseiland, AVS VU Campus, AVS Humanities Lab on City Centre Campus, HvA Venture Centre at the campus in Zuidoost and AVS ahti near AMC also in Zuidoost). […]
More effective surgery through improved alignment of bone segments
Iwan Dobbe is bringing the benefits of modern 3D image analysis and printing technology to the clinic. As a researcher at the Biomedical Engineering and Physics department at AMC he devised a method for the design and production of a patient-specific plate for the alignment of bone segments. It requires a single CT scan, preoperative […]
An idea leads to a research project for which an instrumental set-up is needed
AMC clinical physiologist Peter Sterk’s idea to explore the use of e-nose technology for diagnosis of lung disease has really payed off. His brand-new ‘SpiroNose’ breath analyser will shortly become available for hospitals and general practices. Sterk is confident about the clinical validation studies that are now underway: “The SpiroNose will be a formidable addition […]